SCHEMBL7095886

SCHEMBL7095886

O=C(NCC1CC1)c1ccc(-c2n[nH]c3c2Cc2ccccc2-3)cc1

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CHEK1 O14757 15/20 0.57
KDR P35968 2/20 0.56
CDK1 P06493 1/20 0.53
CDK2 P24941 1/20 0.53
SGK1 O00141 2/20 0.50
AKT1 P31749 2/20 0.50
AKT2 P31751 2/20 0.50
AKT3 Q9Y243 2/20 0.50
CHEK2 O96017 1/20 0.50
PRKCG P05129 1/20 0.50
MARK2 Q7KZI7 1/20 0.50
AURKA O14965 1/20 0.48
CSNK2A2 P19784 1/20 0.48
CSNK2B P67870 1/20 0.48
CSNK2A1 P68400 1/20 0.48
MAPK14 Q16539 1/20 0.46
HDAC3 O15379 1/20 0.46
HDAC4 P56524 1/20 0.46
HDAC1 Q13547 1/20 0.46
HDAC7 Q8WUI4 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6999095 0.95 CHEK1 (0.54) CHEK1KDRCDK1CDK2SGK1
SCHEMBL6999164 0.86 CHEK1 (0.51) CHEK1KDRCDK1CDK2SGK1
SCHEMBL6999161 0.86 CHEK1 (0.51) CHEK1KDRCDK1CDK2SGK1
SCHEMBL7000847 0.86 CHEK1 (0.60) CHEK1KDRCDK1CDK2SGK1
Hydrochloric Acid SCHEMBL7003736 0.86 CHEK1 (0.50) CHEK1KDRCDK1CDK2SGK1
Hydrochloric Acid SCHEMBL7003730 0.86 CHEK1 (0.50) CHEK1KDRCDK1CDK2SGK1
SCHEMBL7095511 0.84 CHEK1 (0.59) CHEK1KDRCDK1CDK2SGK1
SCHEMBL7164708 0.84 CHEK1 (0.59) CHEK1KDRCDK1CDK2SGK1
SCHEMBL6991537 0.83 CHEK1 (0.57) CHEK1KDRCDK1CDK2SGK1
SCHEMBL6994323 0.82 CHEK1 (0.57) CHEK1KDRCDK1CDK2SGK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1127051-A2 TRICYCLIC PYRAZOLE DERIVATIVES BASF AKTIENGESELLSCHAFT (DE) 2001-08-29 EP claimed
WO-2000027822-A2 TRICYCLIC PYRAZOLE DERIVATIVES BASF AKTIENGESELLSCHAFT (DE) 2000-05-18 WO claimed
EP-1289525-A2 TRICYCLIC PYRAZOLE DERIVATIVES AS PROTEIN KINASE INHIBITORS Abbott GmbH & Co. KG (DE) 2003-03-12 EP disclosed
US-6462036-B1 INHIBITING SIGNAL TRANSDUCTION BY MODULATING ACTIVITY OF RECEPTOR AND NONRECEPTOR TYROSINE AND SERINE/THREONINE KINASES TO REGULATE AND MODULATE ABNORMAL OR INAPPROPRIATE CELL PROLIFERATION, DIFFERENTIATION, OR METABOLISM BASF AKTIENGESELLSCHAFT (DE) 2002-10-08 US disclosed
WO-2001087846-A2 TRICYCLIC PYRAZOLE DERIVATIVES AS PROTEIN KINASE INHIBITORS ABBOTT GESELLSCHAFT MIT BESCHRANKTER HAFTUNG & COMPANY KOMMANDITGESELLSCHAFT (DE) 2001-11-22 WO disclosed
EP-1127051-A2 TRICYCLIC PYRAZOLE DERIVATIVES BASF AKTIENGESELLSCHAFT (DE) 2001-08-29 EP disclosed
WO-2000027822-A2 TRICYCLIC PYRAZOLE DERIVATIVES BASF AKTIENGESELLSCHAFT (DE) 2000-05-18 WO disclosed